Drug Use Utilization of Supplements in Covid-19 Patients at the Santa Elisabeth General Hospital Purwokerto

Intan Tia Nurrochmah, Masita Wulandari Suryoputri, Heny Ekowati

Pharmacy Department, Faculty of Health Sciences, Jenderal Soedirman University,

Jl. Dr. Suparno, Karangwangkal, Purwokerto, 53123, Indonesia

Corresponding author: Intan Tia Nurrochmah, Phone : +62857-2646-2933, e-mail :  intan.nurrochmah@mhs.unsoed.ac.id

ABSTRACT

Introduction: COVID-19 is a disease that has spread around the world since March 2020. One of the therapy for COVID-19 patients is supplements to help support immune system. This study aimed to describe the use of supplement therapy in COVID-19 patients hospitalized at the Santa Elisabeth General Hospital Purwokerto.

Method: This study was an observational study with a descriptive cross-sectional design. Data collection was conducted retrospectively based on medical records of COVID-19 inpatients at the Santa Elisabeth General Hospital Purwokerto in April-October 2020. Data in this study were analysed descriptively.

Results: The results showed that the percentage of COVID-19 patients at Elisabeth Hospital was 52.5% female and 47.5% male with more patients under 60 years old, as many as 87.5%. Supplement therapy administered to 40 samples showed that the use of supplements included Vitamin D 23.85%; Zinc 23.85%; Vitamin C 23.08%; Curcuma 22.31%; Multivitamins 5.38%; and Vitamin B 1.54%.

Conclusions: This study indicated that the most widely used supplement therapy in COVID-19 inpatients at Elisabeth Hospital was Vitamin D and Zinc with a percentage of 23.85%.

Keywords: Drug supplements, Covid-19, Santa Elisabeth Hospital Purwokerto